Bisoprolol vs Durvalumab

Bisoprolol vs Durvalumab: Overview

This comparison examines the pharmacological differences between Bisoprolol and Durvalumab.

Mechanism of Action

Bisoprolol: Highly selective beta-1 adrenergic receptor blocker reducing heart rate and myocardial contractility.

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Pharmacokinetics

Half-life: Bisoprolol — 10-12 hours; Durvalumab — 17 days.

Chemical Properties

Molecular Formula: Bisoprolol — C18H31NO4.

Molecular Weight: Bisoprolol — 325.4470 g/mol.

Type: Bisoprolol — Small molecule; Durvalumab — Antibody.